These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

465 related items for PubMed ID: 15471291

  • 21. Kawasaki disease - an Indian perspective.
    Singh S, Kawasaki T.
    Indian Pediatr; 2009 Jul; 46(7):563-71. PubMed ID: 19638655
    [Abstract] [Full Text] [Related]

  • 22. Kawasaki disease in older children and adolescents.
    Stockheim JA, Innocentini N, Shulman ST.
    J Pediatr; 2000 Aug; 137(2):250-2. PubMed ID: 10931420
    [Abstract] [Full Text] [Related]

  • 23. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease.
    Furukawa T, Kishiro M, Akimoto K, Nagata S, Shimizu T, Yamashiro Y.
    Arch Dis Child; 2008 Feb; 93(2):142-6. PubMed ID: 17962370
    [Abstract] [Full Text] [Related]

  • 24. Kawasaki disease in Thai infants compared with older children.
    Sittiwangkul R, Pongprot Y, Thongsongkrit W, Silvilairat S, Phornphutkul C.
    Ann Trop Paediatr; 2004 Mar; 24(1):59-63. PubMed ID: 15005968
    [Abstract] [Full Text] [Related]

  • 25. Epidemiologic features of Kawasaki disease in Taiwan, 1996-2002.
    Chang LY, Chang IS, Lu CY, Chiang BL, Lee CY, Chen PJ, Wang JT, Ho HN, Chen DS, Huang LM, Kawasaki Disease Research Group.
    Pediatrics; 2004 Dec; 114(6):e678-82. PubMed ID: 15574600
    [Abstract] [Full Text] [Related]

  • 26. Initial intravenous gamma-globulin treatment failure in Iranian children with Kawasaki disease.
    Kashef S, Safari M, Amin R.
    Kaohsiung J Med Sci; 2005 Sep; 21(9):401-4. PubMed ID: 16248123
    [Abstract] [Full Text] [Related]

  • 27. Epidemiologic study of Kawasaki disease and cases resistant to IVIG therapy in Thailand.
    Durongpisitkul K, Sangtawesin C, Khongphatthanayopthin A, Panamonta M, Sopontammarak S, Sittiwangkul R, Pongpanich B.
    Asian Pac J Allergy Immunol; 2006 Mar; 24(1):27-32. PubMed ID: 16913186
    [Abstract] [Full Text] [Related]

  • 28. Outcomes of Kawasaki Disease: A Single-Center Experience.
    Uysal F, Bostan OM, Celebi S, Uysal B, Hamitoglu S, Cil E.
    Clin Pediatr (Phila); 2015 Jun; 54(6):579-84. PubMed ID: 25475592
    [Abstract] [Full Text] [Related]

  • 29. [The probability of Kawasaki diseases in young patients with cardiac disorders--retrospective studies].
    Pośnik-Urbańska A, Szymanowska Z, Kawecka-Jaszcz K.
    Przegl Lek; 2003 Jun; 60(12):792-6. PubMed ID: 15058018
    [Abstract] [Full Text] [Related]

  • 30. Epidemiologic features of Kawasaki disease in Taiwan, 2003-2006.
    Huang WC, Huang LM, Chang IS, Chang LY, Chiang BL, Chen PJ, Wu MH, Lue HC, Lee CY, Kawasaki Disease Research Group.
    Pediatrics; 2009 Mar; 123(3):e401-5. PubMed ID: 19237439
    [Abstract] [Full Text] [Related]

  • 31. Intravenous immunoglobulin preparation type: association with outcomes for patients with acute Kawasaki disease.
    Manlhiot C, Yeung RS, Chahal N, McCrindle BW.
    Pediatr Allergy Immunol; 2010 May; 21(3):515-21. PubMed ID: 20546528
    [Abstract] [Full Text] [Related]

  • 32. Clinical responses of patients with Kawasaki disease to different brands of intravenous immunoglobulin.
    Tsai MH, Huang YC, Yen MH, Li CC, Chiu CH, Lin PY, Lin TY, Chang LY.
    J Pediatr; 2006 Jan; 148(1):38-43. PubMed ID: 16423595
    [Abstract] [Full Text] [Related]

  • 33. The diagnosis and management of Kawasaki disease.
    Royle J, Burgner D, Curtis N.
    J Paediatr Child Health; 2005 Mar; 41(3):87-93. PubMed ID: 15790316
    [Abstract] [Full Text] [Related]

  • 34. Evaluation of clinical characteristics of Kawasaki syndrome and risk factors for coronary artery abnormalities among children in Denmark.
    Patel A, Holman RC, Callinan LS, Sreenivasan N, Schonberger LB, Fischer TK, Belay ED.
    Acta Paediatr; 2013 Apr; 102(4):385-90. PubMed ID: 23278838
    [Abstract] [Full Text] [Related]

  • 35. Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan.
    Uehara R, Belay ED, Maddox RA, Holman RC, Nakamura Y, Yashiro M, Oki I, Ogino H, Schonberger LB, Yanagawa H.
    Pediatr Infect Dis J; 2008 Feb; 27(2):155-60. PubMed ID: 18174868
    [Abstract] [Full Text] [Related]

  • 36. Epidemiological survey of Kawasaki disease in Sichuan province of China.
    Li XH, Li XJ, Li H, Xu M, Zhou M.
    J Trop Pediatr; 2008 Apr; 54(2):133-6. PubMed ID: 17965438
    [Abstract] [Full Text] [Related]

  • 37. Pattern of clinical features of Kawasaki disease.
    Muzaffer MA, Al-Mayouf SM.
    Saudi Med J; 2002 Apr; 23(4):409-12. PubMed ID: 11953766
    [Abstract] [Full Text] [Related]

  • 38. [Incidence of Kawasaki disease].
    Klevberg S, Farstad T, Perminow KV.
    Tidsskr Nor Laegeforen; 2004 Jul 01; 124(13-14):1774-5. PubMed ID: 15229665
    [Abstract] [Full Text] [Related]

  • 39. The Harada score in the US population of children with Kawasaki disease.
    Tewelde H, Yoon J, Van Ittersum W, Worley S, Preminger T, Goldfarb J.
    Hosp Pediatr; 2014 Jul 01; 4(4):233-8. PubMed ID: 24986993
    [Abstract] [Full Text] [Related]

  • 40. Epidemiologic study on Kawasaki disease in Beijing from 2000 through 2004.
    Du ZD, Zhao D, Du J, Zhang YL, Lin Y, Liu C, Zhang T, Beijing Kawasaki Research Group.
    Pediatr Infect Dis J; 2007 May 01; 26(5):449-51. PubMed ID: 17468660
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.